Treatment-emergent tardive dyskinesia in patients receiving aripiprazole or haloperidol for the treatment of schizophrenia or schizoaffective disorder

被引：0
|
作者：
Miller, D. D. [1 ]
Kim, E. [1 ]
Eudicone, J. [1 ]
Pikalov, A. [1 ]
Vester-Blokland, E. [1 ]
机构：
[1] Univ Iowa, Carver Coll Med, Iowa City, IA USA
来源：
SCHIZOPHRENIA BULLETIN | 2007年 / 33卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
引用
收藏
页码：503 / 503
页数：1
相关论文
共 50 条
  • [21] Treatment Outcomes of Patients With Tardive Dyskinesia and Chronic Schizophrenia
    Caroff, Stanley N.
    Davis, Vicki G.
    Miller, Del D.
    Davis, Sonia M.
    Rosenheck, Robert A.
    McEvoy, Joseph P.
    Campbell, E. Cabrina
    Saltz, Bruce L.
    Riggio, Silvana
    Chakos, Miranda H.
    Swartz, Marvin S.
    Keefe, Richard S. E.
    Stroup, T. Scott
    Lieberman, Jeffrey A.
    JOURNAL OF CLINICAL PSYCHIATRY, 2011, 72 (03) : 295 - 303
  • [22] Aripiprazole for Patients with Schizophrenia and Schizoaffective Disorder: An Open-Label, Randomized, Study Versus Haloperidol
    de Oliveira, Irismar Reis
    Elkis, Helio
    Gattaz, Wagner Farid
    Chaves, Ana Cristina
    de Sena, Eduardo Ponde
    de Matos e Souza, Fabio Gomes
    Campos, Joao Alberto
    Bueno, Joao Romildo
    Costa e Silva, Jorge Alberto
    Louza, Mario Rodrigues
    de Abreu, Paulo Belmonte
    CNS SPECTRUMS, 2009, 14 (02) : 93 - 102
  • [23] Efficacy and safety of intramuscular aripiprazole, haloperidol or placebo in acutely agitated patients with schizophrenia or schizoaffective disorder
    Oren, D
    Marcus, R
    Kostic, D
    McQuade, R
    Iwamoto, T
    Archibald, D
    SCHIZOPHRENIA BULLETIN, 2005, 31 (02) : 499 - 499
  • [24] Incidence, onset, and duration of treatment-emergent somnolence with asenapine in patients with schizophrenia or bipolar disorder
    Cazorla, P.
    Zhao, J.
    Szegedi, A.
    BIPOLAR DISORDERS, 2011, 13 : 34 - 34
  • [25] INCIDENCE, ONSET AND DURATION OF TREATMENT-EMERGENT SOMNOLENCE WITH ASENAPINE IN PATIENTS WITH SCHIZOPHRENIA OR BIPOLAR DISORDER
    Cazorla, P.
    Zhao, J.
    Szegedi, A.
    EUROPEAN PSYCHIATRY, 2012, 27
  • [26] Treatment of tardive dyskinesia in patients with bipolar disorder by risperidone
    Mino, K
    Shirakawa, O
    Hashimoto, T
    Ono, H
    Iwao, S
    Matsuishi, K
    Yamaguchi, N
    Maeda, K
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2002, 17 : S75 - S76
  • [27] Incidence, onset, and duration of treatment-emergent somnolence with asenapine in patients with schizophrenia or bipolar disorder
    Cazorla, P.
    Zhao, J.
    Szegedi, A.
    BIPOLAR DISORDERS, 2012, 14 : 128 - 128
  • [28] Risk of treatment-emergent diabetes Mellitus in patients receiving antipsychotics
    Citrome, Leslie L.
    Holt, Richard I. G.
    Zachry, Woodie M.
    Clewell, Jerry D.
    Orth, Paul A.
    Karagianis, Jamie L.
    Hoffmann, Vicki Poole
    ANNALS OF PHARMACOTHERAPY, 2007, 41 (10) : 1593 - 1603
  • [29] Intramuscular aripiprazole for the treatment of acute agitation in patients with schizophrenia or schizoaffective disorder: a double-blind, placebo-controlled comparison with intramuscular haloperidol
    Andrezina, Raisa
    Josiassen, Richard C.
    Marcus, Ronald N.
    Oren, Dan A.
    Manos, George
    Stock, Elyse
    Carson, William H.
    Iwamoto, Taro
    PSYCHOPHARMACOLOGY, 2006, 188 (03) : 281 - 292
  • [30] Intramuscular aripiprazole for the treatment of acute agitation in patients with schizophrenia or schizoaffective disorder: a double-blind, placebo-controlled comparison with intramuscular haloperidol
    Raisa Andrezina
    Richard C. Josiassen
    Ronald N. Marcus
    Dan A. Oren
    George Manos
    Elyse Stock
    William H. Carson
    Taro Iwamoto
    Psychopharmacology, 2006, 188 : 281 - 292
12345